Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
214,467,875
-
Total 13F shares
-
18,346,444
-
Share change
-
+2,157,199
-
Total reported value
-
$170,228,516
-
Put/Call ratio
-
54%
-
Price per share
-
$9.28
-
Number of holders
-
73
-
Value change
-
+$20,289,375
-
Number of buys
-
40
-
Number of sells
-
28
Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2017
As of 31 Mar 2017,
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,346,444 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, SV Health Investors, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., COLUMBUS CIRCLE INVESTORS, VANGUARD GROUP INC, MORGAN STANLEY, and Opaleye Management Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.